Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Expensive Celgene Shares A Better Bet Than Most Biotechs
Expensive Celgene Shares A Better Bet Than Most Biotechs
Expensive Celgene Shares A Better Bet Than Most Biotechs
Submitted by
admin
on April 5, 2012 - 9:10pm
Source:
Seeking Alpha
News Tags:
Celgene
JNJ
ONYX Pharmaceuticals
Revlimid
Pfizer
Headline:
Expensive Celgene Shares A Better Bet Than Most Biotechs
Do Not Allow Advertisers to Use My Personal information
